Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Rezivertinib | 1835667-12-3 | 486.57 | 50 MG
Supplier: Medchemexpress LLC HY109189500MG
Rezivertinib (BPI-7711) is an orally active, highly selective and irreversible third-generation EGFR tyrosine kinase inhibitor (TKI). It demonstrates high potency against common activation EGFR and resistance T790M mutations. Rezivertinib also exhibits excellent central nervous system (CNS) penetration and has antitumor activity.
- Orally active
- Highly selective
- Irreversible third-generation EGFR tyrosine kinase inhibitor
- Potent against common activation EGFR mutations
- Potent against resistance T790M mutations
- Excellent central nervous system (CNS) penetration
- Antitumor activity
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?